Cell Source Inc - ESG Rating & Company Profile powered by AI
The ESG rating for Cell Source Inc indicates its transparency towards the United Nations Sustainable Development Goals. The page displays a zero-cost ESG report for Cell Source Inc. The report of Cell Source Inc incorporates information from across the internet and also from available disclosures by Cell Source Inc.
Cell Source Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.2; made up of an environmental score of 4.0, social score of 5.3 and governance score of 3.4.
4.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1335 | PureTech Health PLC | 4.3 | High |
| 1335 | Youcare Pharmaceutical Group Co Ltd | 4.3 | High |
| 1376 | Cell Source Inc | 4.2 | High |
| 1376 | Atreca Inc | 4.2 | High |
| 1376 | BiondVax Pharmaceuticals Ltd | 4.2 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cell Source Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cell Source Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cell Source Inc report the average age of the workforce?
Sign up for free to unlockDoes Cell Source Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cell Source Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cell Source Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cell Source Inc offer flexible work?
Sign up for free to unlockDoes Cell Source Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cell Source Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cell Source Inc conduct supply chain audits?
Sign up for free to unlockDoes Cell Source Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cell Source Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cell Source Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cell Source Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cell Source Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cell Source Inc disclose water use targets?
Sign up for free to unlockDoes Cell Source Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cell Source Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cell Source Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cell Source Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cell Source Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cell Source Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cell Source Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cell Source Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cell Source Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cell Source Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cell Source Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cell Source Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cell Source Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cell Source Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cell Source Inc disclose its waste policy?
Sign up for free to unlockDoes Cell Source Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cell Source Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cell Source Inc disclose energy use targets?
Sign up for free to unlockDoes Cell Source Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cell Source Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cell Source Inc
These potential risks are based on the size, segment and geographies of the company.
Cell Source, Inc., a biotechnology company, develops cell therapy treatments. The company's lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. Its Veto Cell technology is used in various applications, such as treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease and other non-malignant organ diseases, and various cancers and non-malignant diseases. The company was founded in 2011 and is headquartered in New York, New York.